Alteplase beyond three hours in ischemic stroke: do we know enough?

Int J Stroke. 2009 Apr;4(2):70. doi: 10.1111/j.1747-4949.2009.00255.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Recovery of Function
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / administration & dosage*
  • Tissue Plasminogen Activator / adverse effects*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator